Tag: Reports

-- Statistically significant week 96 results from the Phase 2b HARMONY study of EFX in patients with pre-cirrhotic MASH reported ...

-- Announced FDA clearance of first-ever IND application for a Prime Editing product, PM359, for the treatment of CGD; initial ...

- Belrestotug + dostarlimab exceeded pre-defined efficacy criteria for clinically relevant activity observed in an interim assessment of Phase 2 ...

WALTHAM, Mass., May 10, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology ...

$126.3 Million In Total Gross Proceeds from Warrant Distribution.Over 1,900 Patients with Alzheimer’s Disease Are Randomized in Phase 3 Trials ...

JERUSALEM, May 10, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the ...

ALLEN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ...

Mumbai, Maharashtra, India The Board has recommended issue of bonus shares in the ratio ...

ARR up 21% YoY to $47.8 millionTotal Revenue up 21% to $15.3 millionEBITDA up 56% YoY to $3.1 million TORONTO, ...

Practice Collections +7.4% compared to 1Q’23Implemented Providers +17.3% compared to 1Q’23Company Reiterated Full Year 2024 Guidance ARLINGTON, Va., May 09, ...